Iaci, Jennifer,Caggiano, Anthony,Ganguly, Anindita,Parry, Tom
申请号：
AU2017203528
公开号：
AU2017203528A1
申请日:
2017.05.26
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017203528A120170615.pdf#####ABSTRACT The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
